Leadership

Our proven executive team brings deep, diverse cell therapy experience and is committed to developing safe, effective, and accessible NK cell therapies to patients. Artiva's Board of Directors and Advisors bring years of expertise to help us realize the full potential of NK cell therapies.

Stanley Cohen, M.D.
Stanley Cohen, M.D.
RA Advisory Board
View Bio »
Jonathan Kay, M.D., FACP, MACR
Jonathan Kay, M.D., FACP, MACR
RA Advisory Board
View Bio »
Michael E. Weinblatt, M.D.
Michael E. Weinblatt, M.D.
RA Advisory Board
View Bio »
Secret Link